FindTrial
Sign In

Testing Magnetic Field and Decongestive Therapy to Reduce Swelling and Improve Blood Flow in Women with Arm Lymphedema after Breast Cancer Surgery

Effectiveness of Pulsed Electromagnetic Field Therapy Combined with Complex Decongestive Therapy on Limb Volume and Blood Circulation in Lymphedema Following Modified Radical Mastectomy: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110127
Enrollment
120
Registered
2026-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Pulsed Electromagnetic Field Therapy + Complex Decongestive Therapy [Experimental]: PEMF Therapy plus Frequency: 10 Hz (optimal for circulation per Strauch et al., 2009) Magnetic Flux

Sponsors

Amity Institute of Health Allied Sciences Amity University
Lead Sponsor
Metro Heart Institute with Multispecialty Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Modified Radical Mastectomy with Axillary Lymph Node Dissection (10 lymph nodes removed) for unilateral breast cancer. Completed all cancer treatment 2 years prior. Unilateral upper extremity lymphedema: 2 cm circumference difference OR 10% volume increase versus contralateral limb Lymphedema present 6 months (chronic) Stable lymphedema (no acute exacerbations past 3 months) Able to attend 44 supervised sessions over 12 weeks. Informed consent in English or Hindi

Exclusion criteria

Exclusion criteria: Bilateral lymphedema; Primary lymphedema Non-Modified Radical Mastoidectomy surgery (breast conservation, simple mastectomy, Sentinel Lymph Node Biopsy only with 10 nodes) Active cancer or suspected recurrence Acute infection (cellulitis) past 3 months Recent surgery/trauma to affected limb (6 months) Uncontrolled heart failure, renal failure, liver cirrhosis PEMF contraindications: Cardiac pacemaker, Implantable Cardioverter-Defibrillator, metallic implants in limb, pregnancy Cognitive impairment preventing consent.

Design outcomes

Primary

MeasureTime frame
Limb Volume Blood Circulation Timepoint: 0, 4, 8, 12 Weeks—

Secondary

MeasureTime frame
Limb Circumference Shoulder Range of Motion Pain Intensity Grip StrengthTimepoint: 0, 4, 8, 12 Weeks—

Countries

India

Contacts

Public ContactDr Nidhi Sharma

Amity Institute of Health Allied Sciences, Amity University, Uttar Pradesh,

sharmanidhiphysio@gmail.com9760835605

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026